1315 Capital Provides Growth Financing to ProSciento
September 10, 2020
ProSciento, a San Diego–based specialty clinical research organization focused on NASH, diabetes and obesity, closed a growth financing round with healthcare investor 1315 Capital. The capital will support expansion of ProSciento's CRO operations and growth of its patient access solutions, including the NASH PASS registry.
- Buyers
- 1315 Capital
- Targets
- ProSciento, Inc.
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
1315 Capital Invests in Primrose Bio
June 17, 2024
Biotechnology
1315 Capital, a Philadelphia-based healthcare-focused growth equity firm, made a significant equity investment in Primrose Bio to support development and commercial expansion of Primrose’s nucleic acid and protein manufacturing technologies. The funding will accelerate commercialization of the company’s Prima RNApols, Pfenex expression system, and PeliCRM carrier protein for therapeutics and vaccines.
-
1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
Pharmaceuticals
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
1315 Capital Leads Growth Investment in Experic
October 29, 2024
Pharmaceuticals
Experic, a Cranbury, New Jersey-based CDMO and clinical trial supply services firm, received a growth capital investment led by 1315 Capital with participation from existing investors East Seattle Partners, Harro Höfliger Packaging Systems, Inc., and Kineticos Ventures. The capital will be used to enhance Experic’s manufacturing capabilities and accelerate its international expansion to better serve biopharmaceutical clients.
-
1315 Capital Acquires Biocoat, Inc.
January 16, 2019
Medical Devices
Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.
-
Cressey & Company and Sunstone Partners Make Growth Investment in ProgenyHealth
May 20, 2025
Healthcare Services
ProgenyHealth, a Plymouth Meeting, Pennsylvania–based leader in maternity and NICU care management, received a significant growth investment from Cressey & Company alongside existing investor Sunstone Partners. The capital and Cressey's healthcare expertise will support ProgenyHealth’s continued expansion of its tech-enabled maternity and NICU care management services and platform.
-
Serent Capital Invests in Procurement Partners
December 3, 2020
Cloud & SaaS
Serent Capital has made a growth investment in Procurement Partners, a Champaign, Illinois–based provider of a procure-to-pay (P2P) eProcurement platform serving healthcare providers. The investment will provide capital and Serent’s growth resources to help Procurement Partners scale its platform, expand its team, and reach more healthcare customers across the United States.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.